Vienna BioCenter Core Facilities (VBCF): € 60 million investment

The Vienna BioCenter constitutes one of the most outstanding and prominent life sciences hubs in Central Europe. Its research infrastructure (VBCF) provides access to a cutting-edge instruments, expertise and experience, enabling breakthrough discoveries. Its cost-efficient services are available for academia and business.

The Austrian Federal Ministry of Education, Science and Research and the City of Vienna invest another € 60 million to maintain and develop cutting-edge research infrastructure and the expert pool at the VBCF. This will allow to meet new demands sparked by the growth of the campus. LISAvienna’s managing directors Johannes Sarx and Philip Hainzl note: “The Vienna BioCenter Core Facilities provide a competitive advantage to innovators in Vienna. We strongly encourage start-up companies and SMEs to reach out to its experts for improving pipeline projects and increasing their success rate.”

Daniele Soroldoni, Managing Director VBCF, adds: “The Vienna BioCenter Core Facilities are a key driver of Vienna BioCenter’s remarkable journey towards success. Our shared core facilities were a bold and visionary move a decade ago, one that became an internationally followed model. We are looking forward to further advancing our facilities and services in the future.”

Young companies in the Vienna Business Agency’s Startup Labs such as a:head bio, Proxygen and QUANTRO Therapeutics highly appreciate VBCF's services. Start-ups are typically interested in the following services:

  • Next generation sequencing: All common NGS sequencing applications are available, and novel methods and protocols are in development. VBCF’s experts provide advice and guidance to make sequencing projects a success.
  • Metabolomics: Both targeted and non-targeted metabolomics analysis are provided, revealing changes in metabolic pathways, consequences of perturbations or quantifying small molecules and metabolites of any origin. So far, the VBCF has established methods for some 1,000 molecules.
  • Protein technologies: Services include molecular cloning, protein production and purification, and biophysical characterization.
  • (Cryo-)Electron Microscopy: A wide range of preparation and visualization techniques is offered for biological samples ranging from standard methods to cutting-edge cryo-EM for high-resolution 2D or 3D imaging.
  • Plant sciences: Highly specialized plant growth chambers and professional support for green research are available. The focus is on environmental simulation, high-throughput plant phenotyping and subsequent image and data processing.

Further details and information on the entire service portfolio can be found online:

Additional opportunities

In Vienna, advanced scientific equipment also is available at the MedUni Vienna / AKH campus, at TU Wien, and Vetmeduni Vienna. BOKU EQ provides access to an extreme climate chamber or bioreactor pilot plant facilities. Information on additional facilities are provided in Austria’s award-winning research infrastructure database operated by the Austrian Federal Ministry for Education, Science and Research:

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)